Bravi Francesca, Ruscio Eugenio Di, Frassoldati Antonio, Cavallesco Giorgio Narciso, Valpiani Giorgia, Ferrozzi Anna, Wienand Ulrich, Carradori Tiziano
Research Innovation Quality and Accreditation Unit, S. Anna University Hospital of Ferrara, Ferrara, IT.
S. Anna University Hospital of Ferrara, Ferrara, IT.
Int J Integr Care. 2018 Oct 31;18(4):7. doi: 10.5334/ijic.3972.
The purpose of this study was to evaluate the perception of the quality of care, considering both patient experience and health care professionals' perceptions as well as patient outcome measures of an integrated lung cancer pathway.
A cross-sectional study was conducted in 2016 at Ferrara University Hospital, Italy. OPportunity for Treatment In ONcology (OPTION) questionnaires were administered to 77 patients, and the Care Process Self-Evaluation Tool (CPSET) questionnaires were given to 38 health care professionals. The effectiveness of the pathway was evaluated by analysing the tool's positive impact on lung cancer surgery volume and 30-day mortality.
Seventy-seven patients were enrolled, and 38 health care professionals assessed the CPSET questionnaire. The highest scores were related to "respect" (100%), "satisfaction" (98.7%), and "trust" (97.4%) on the OPTION and to "patient-focused vision" (97.2%) and "patient engagement" (94.4%) on the CPSET. The lowest scores were related to "information" (26%) and "cooperation with general practitioner" (17.6%) on the OPTION and "cooperation between the hospital and primary care" (23.5%) for the CPSET. The outcomes analysis shows an increase in the volume of activity and a decrease in 30-day mortality after pathway implementation.
The lung cancer pathway is a patient-centred intervention that enables care to be shaped for patient needs in order to improve the quality and efficiency of service and clinical outcome.
本研究的目的是评估对医疗质量的认知，同时考虑患者体验、医疗保健专业人员的看法以及综合肺癌治疗路径的患者结局指标。
2016年在意大利费拉拉大学医院进行了一项横断面研究。对77名患者进行了肿瘤治疗机会（OPTION）问卷调查，并向38名医疗保健专业人员发放了护理过程自我评估工具（CPSET）问卷。通过分析该工具对肺癌手术量和30天死亡率的积极影响来评估该治疗路径的有效性。
纳入了77名患者，38名医疗保健专业人员对CPSET问卷进行了评估。OPTION问卷中得分最高的是“尊重”（100%）、“满意度”（98.7%）和“信任”（97.4%），CPSET问卷中得分最高的是“以患者为中心的愿景”（97.2%）和“患者参与度”（94.4%）。OPTION问卷中得分最低的是“信息”（26%）和“与全科医生的合作”（17.6%），CPSET问卷中得分最低的是“医院与初级保健之间的合作”（23.5%）。结局分析显示，实施该治疗路径后活动量增加，30天死亡率降低。
肺癌治疗路径是以患者为中心的干预措施，能够根据患者需求调整护理，以提高服务质量和效率以及临床结局。
